Trial Phase
Trial Status
Paid Participation
Clear All
27 Belantamab Mafodotin Trials Near You
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerTrial Details
Key Eligibility Criteria
88 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
325 Participants Needed
Belantamab Mafodotin vs. Daratumumab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
494 Participants Needed
Belantamab Mafodotin + Pd vs Bortezomib + Pd for Multiple Myeloma
Trial Details
Key Eligibility Criteria
302 Participants Needed
Isatuximab Combination Therapy for Multiple Myeloma
Trial Details
Key Eligibility Criteria
258 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
36 Participants Needed
Belantamab Mafodotin Combinations for Multiple Myeloma
Trial Details
Key Eligibility Criteria
209 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
28 Participants Needed
Belantamab Mafodotin + SoC for Multiple Myeloma
Trial Details
Key Eligibility Criteria
118 Participants Needed
Combination Therapy for Multiple Myeloma
Trial Details
Key Eligibility Criteria
83 Participants Needed
Belantamab Mafodotin + Lenalidomide for Multiple Myeloma
Trial Details
Key Eligibility Criteria
20 Participants Needed
Quadruple Therapy for Multiple Myeloma
Trial Details
Key Eligibility Criteria
70 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
177 Participants Needed
Combination Therapies with Selinexor for Multiple Myeloma
Trial Details
Key Eligibility Criteria
300 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
33 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
47 Participants Needed
Belantamab for Lupus
Trial Details
Key Eligibility Criteria
16 Participants Needed
Trial Details
Key Eligibility Criteria
34 Participants Needed
Belantamab Mafodotin + Nirogacestat + Pomalidomide for Multiple Myeloma
Trial Details
Key Eligibility Criteria
9 Participants Needed
Belantamab Mafodotin for Lymphoma
Trial Details
Key Eligibility Criteria
25 Participants Needed
Belantamab + Elotuzumab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
24 Participants Needed
Belantamab Mafodotin for AL Amyloidosis
Trial Details
Key Eligibility Criteria
37 Participants Needed
Isatuximab + Belantamab for Multiple Myeloma
Trial Details
Key Eligibility Criteria
50 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
62 Participants Needed
Belantamab Mafodotin + Lenalidomide for Multiple Myeloma
Trial Details
Key Eligibility Criteria
94 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
30 Participants Needed
Belantamab Mafodotin for Multiple Myeloma
Trial Details
Key Eligibility Criteria
20 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.